Skip to main content
. 2020 Sep 18;20(5):117. doi: 10.3892/etm.2020.9245

Figure 1.

Figure 1

Irbesartan inhibits the activity of the TGFβ1/Smad2/3 pathway in the myocardium in diabetic rats. (A) Western blot analysis of protein expression in the rat myocardium. (B) Statistical comparison of protein expression in the rat myocardium between the two groups. *P<0.05 vs. DCM group. DCM, diabetic cardiomyopathy; TGFβ1, transforming growth factor β1; p-, phosphorylated.